Authors:
Berencsi, K
Gyulai, Z
Gonczol, E
Pincus, S
Cox, WI
Michelson, S
Kari, L
Meric, C
Cadoz, M
Zahradnik, J
Starr, S
Plotkin, S
Citation: K. Berencsi et al., A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects, J INFEC DIS, 183(8), 2001, pp. 1171-1179
Authors:
Wittes, RC
Bohle, A
Bakshi, S
Bretscher, P
Brewer, T
Clements, D
Fanning, A
Flad, H
Garcia, LF
Gheorghiu, M
Hershfield, E
Hoft, D
Jewett, M
Kunimoto, D
Lamm, D
Marks, D
Menzies, R
Mosmann, T
Plotkin, S
Prescott, S
Ratliff, T
Schamhart, D
Smith, D
Tilley, P
Ward, B
Citation: Rc. Wittes et al., Bacille Calmette-Guerin vaccine - Discussion, CLIN INF D, 31, 2000, pp. S115-S121
Authors:
Reef, SE
Plotkin, S
Cordero, JF
Katz, M
Cooper, L
Schwartz, B
Zimmerman-Swain, L
Danovaro-Holliday, MC
Wharton, M
Citation: Se. Reef et al., Preparing for elimination of congenital rubella syndrome (CRS): Summary ofa workshop on CRS elimination in the United States, CLIN INF D, 31(1), 2000, pp. 85
Authors:
Gyulai, Z
Endresz, V
Burian, K
Pincus, S
Toldy, J
Cox, WI
Meric, C
Plotkin, S
Gonczol, E
Berencsi, K
Citation: Z. Gyulai et al., Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs, J INFEC DIS, 181(5), 2000, pp. 1537-1546
Authors:
Salmon-Ceron, D
Excler, JL
Finkielsztein, L
Autran, B
Gluckman, JC
Sicard, D
Matthews, TJ
Meignier, B
Valentin, C
El Habib, R
Blondeau, C
Raux, M
Moog, C
Tartaglia, J
Chong, P
Klein, M
Milcamps, B
Heshmati, F
Plotkin, S
Citation: D. Salmon-ceron et al., Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection, AIDS RES H, 15(7), 1999, pp. 633-645
Citation: S. Plotkin, Technologies and policies for controlling greenhouse gas emissions from the US automobile and light truck fleet, TRANSP Q, 53(2), 1999, pp. 7-30
Authors:
Lang, J
Rongrre, N
Plotkin, S
Hoa, DQ
Gioi, NV
Tho, LT
Citation: J. Lang et al., Booster vaccination at 1 year with a rabies vaccine associated with DTP-IPV in infants living in a rabies endemic country, J TROP PEDI, 45(3), 1999, pp. 181-183
Authors:
Peter, G
des-Vignes-Kendrick, M
Eickhoff, TC
Fine, A
Galvin, V
Levine, MM
Maldonado, YA
Marcuse, EK
Monath, TPC
Osborn, JE
Macy, J
Plotkin, S
Poland, GA
Quinlisk, MP
Smith, DR
Sokol, M
Soland, DB
Whitley-Williams, PN
Williamson, DE
Breiman, RF
Arvin, A
Baylor, N
Breiman, R
Clements-Mann, ML
Couch, R
Douglas, G
Galambos, L
Gellin, B
Gershon, A
Glass, R
Gordon, L
Glode, M
Greenberg, H
Hardegree, C
Heilman, C
Hilleman, M
Jordan, W
Levine, MM
Marcuse, E
Paradiso, P
Parkman, P
Plotkin, S
Quinnan, G
Rabinovich, R
Read, L
Russell, P
Sewell, J
Shepherd, HR
Siber, G
Soland, D
Ward, J
White, J
Wright, P
Citation: G. Peter et al., Lessons learned from a review of the development of selected vaccines, PEDIATRICS, 104(4), 1999, pp. 942-950
Citation: S. Plotkin et P. Saliou, From collective vaccination to vaccination 'for personal reasons'., PUBLIC HEALTH AND UNIVERSAL ETHICS, 1999, pp. 49-56
Citation: P. Saliou et S. Plotkin, Vaccination in adults: should it be systematic or 'a la carte'?, PUBLIC HEALTH AND UNIVERSAL ETHICS, 1999, pp. 57-59